Akers Biosciences Company Profile (NASDAQ:AKER)

About Akers Biosciences

Akers Biosciences logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AKER
  • CUSIP:
Key Metrics:
  • Previous Close: $1.25
  • 50 Day Moving Average: $1.26
  • 200 Day Moving Average: $2.42
  • 52-Week Range: $1.15 - $3.70
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.33
  • P/E Growth: 0.00
  • Market Cap: $7.09M
  • Outstanding Shares: 5,452,000
  • Beta: -0.06
Profitability:
  • Net Margins: -208.32%
  • Return on Equity: -114.05%
  • Return on Assets: -87.75%
Debt:
  • Current Ratio: 2.95%
  • Quick Ratio: 1.46%
Additional Links:
Companies Related to Akers Biosciences:

Analyst Ratings

Consensus Ratings for Akers Biosciences (NASDAQ:AKER) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Akers Biosciences (NASDAQ:AKER)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Akers Biosciences (NASDAQ:AKER)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/28/2017        
11/13/2015Q315($0.45)ViewListenView Earnings Details
8/18/2015Q215($0.41)$1.35 millionViewListenView Earnings Details
5/14/2015Q115($0.10)($0.26)$2.00 millionViewListenView Earnings Details
3/23/2015($0.16)($0.18)ViewN/AView Earnings Details
11/13/2014Q314($0.17)($0.23)$1.40 million$453.30 millionViewN/AView Earnings Details
8/12/2014($0.16)($0.10)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Akers Biosciences (NASDAQ:AKER)
Current Year EPS Consensus Estimate: $-1.24 EPS
Next Year EPS Consensus Estimate: $-0.30 EPS

Dividends

Dividend History for Akers Biosciences (NASDAQ:AKER)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Akers Biosciences (NASDAQ:AKER)
Insider Ownership Percentage: 16.31%
Institutional Ownership Percentage: 3.24%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/24/2016John J GormallyCEOBuy2,500$2.23$5,575.00View SEC Filing  
1/5/2016Raymond Francis Akers JrChairmanBuy2,100$1.34$2,814.00View SEC Filing  
12/11/2015Gary M RauchVPBuy3,500$1.50$5,250.00View SEC Filing  
8/22/2014Gary M RauchVPBuy1,020$3.15$3,213.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Akers Biosciences (NASDAQ:AKER)
DateHeadline
News IconAkers Biosciences, Inc. AKER Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:AKER)
www.bioportfolio.com - February 22 at 8:29 PM
News IconBreath Analyzers Market 2015-2025 Shares, Trend and Growth Report (NASDAQ:AKER)
reports.pr-inside.com - February 16 at 7:37 AM
morningstar.co.uk logoAkers Gets US Patent For Cartridge Used In BreathScan Lync (NASDAQ:AKER)
www.morningstar.co.uk - February 16 at 7:37 AM
marketwired.com logoAkers Biosciences Allowed US Patent for Akers Wellness™ Tests Cartridge (NASDAQ:AKER)
www.marketwired.com - February 16 at 7:37 AM
finance.yahoo.com logoAkers Biosciences Allowed US Patent for Akers Wellness(TM) Tests Cartridge (NASDAQ:AKER)
finance.yahoo.com - February 16 at 7:37 AM
newsmaker.com.au logo$1,600.0 Mn for Global Breath Analyzers Market by 2022 (NASDAQ:AKER)
www.newsmaker.com.au - February 8 at 3:37 PM
stockmarketwire.com logoAkers Bio revenues up 66% (NASDAQ:AKER)
www.stockmarketwire.com - February 1 at 3:33 PM
sbwire.com logoWorldwide Breath Analyzers Market Sizing with Competitive Landscape by 2021 (NASDAQ:AKER)
www.sbwire.com - January 24 at 1:30 AM
News IconGlobal Breath Analyzers Market Revenue Predicted to USD 1,600.0 million in 2021 (NASDAQ:AKER)
www.medgadget.com - January 17 at 4:04 PM
4-traders.com logoAKERS BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K) (NASDAQ:AKER)
www.4-traders.com - January 14 at 1:52 AM
finance.yahoo.com logoAkers Biosciences Announces Closing of Public Offering (NASDAQ:AKER)
finance.yahoo.com - January 13 at 8:51 PM
4-traders.com logoAkers Biosciences : To Issue Additional Shares In Over-Allotment Option (ALLISS) (NASDAQ:AKER)
www.4-traders.com - January 13 at 3:49 PM
streetinsider.com logoForm 8-K Akers Biosciences Inc For: Jan 13 (NASDAQ:AKER)
www.streetinsider.com - January 13 at 3:49 PM
biz.yahoo.com logoAKERS BIOSCIENCES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:AKER)
biz.yahoo.com - January 13 at 3:49 PM
biz.yahoo.com logoAKERS BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:AKER)
biz.yahoo.com - January 10 at 8:30 PM
reuters.com logoBRIEF-Akers Biosciences prices 1.6 mln share offering at $1.20 per share (NASDAQ:AKER)
www.reuters.com - January 10 at 3:28 PM
finance.yahoo.com logo3:20 am Akers Biosciences prices 1,667,000 shares of common stock at $1.20 per share, together with 833,500 five-year warrants to purchase common stock with an exercise price of $1.50 (NASDAQ:AKER)
finance.yahoo.com - January 10 at 3:28 PM
marketwatch.com logoAkers Biosciences Announces Pricing of Public Offering of 1,667,000 Shares and 833,500 Warrants (NASDAQ:AKER)
www.marketwatch.com - January 9 at 8:39 PM
News IconGlobal Alcohol Breathalyzer and Drug Testing Equipment Market by Product & Data Validation, Analysis and Forecast 2022 (NASDAQ:AKER)
emailwire.com - January 9 at 3:38 PM
openpr.com logoWorld Breath Analyzers Market Status 2022 (NASDAQ:AKER)
www.openpr.com - January 9 at 1:28 AM
streetinsider.com logoForm 424B5 Akers Biosciences Inc (NASDAQ:AKER)
www.streetinsider.com - January 6 at 3:32 PM
biz.yahoo.com logoAKERS BIOSCIENCES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:AKER)
biz.yahoo.com - December 22 at 8:29 PM
einnews.com logoResident doctors at Aga Khan Hospital show support for striking counterparts (NASDAQ:AKER)
automotive.einnews.com - December 22 at 3:27 PM
einnews.com logoThe top 10 cloud stories of 2016 (NASDAQ:AKER)
brazilbusiness.einnews.com - December 22 at 3:27 PM
baystreet.ca logoAkers Biosciences (AKER) Gains on New York State deal (NASDAQ:AKER)
www.baystreet.ca - December 22 at 3:27 PM
4-traders.com logoAkers Biosciences : Fiat Chrysler Automobiles Stocks Gainers/Losers Roundup-Akers Biosciences (AKER), Integrated Device Technology (IDTI) (NASDAQ:AKER)
www.4-traders.com - December 21 at 4:29 PM
einnews.com logoOS builder Thundersoft buys UI maker Rightware for $68M to expand in automotive (NASDAQ:AKER)
automotive.einnews.com - December 20 at 8:30 PM
News IconAkers Bio resolutions passed at AGM (NASDAQ:AKER)
www.youinvest.co.uk - December 20 at 9:04 AM
morningstar.co.uk logoAkers Biosciences Signs Rapid Test Deal With US Hospital Association (NASDAQ:AKER)
www.morningstar.co.uk - December 20 at 9:04 AM
4-traders.com logoAkers Biosciences : Agreement with GNYHA for PIFA Heparin PF4 Test (NASDAQ:AKER)
www.4-traders.com - December 20 at 9:04 AM
News IconAlcohol Breathalyzer and Drug Testing Equipment Market by Product & Data Validation, Analysis and Forecast 2022 (NASDAQ:AKER)
www.emailwire.com - December 19 at 3:36 PM
einnews.com logoAt least 33 die in Russian city from alcohol poisoning (NASDAQ:AKER)
brazilbusiness.einnews.com - December 19 at 3:36 PM
streetinsider.com logoAkers Biosciences (AKER) Signs Three Agreement with GNYHA to Introduce Heparin PF4 Rapid Test (NASDAQ:AKER)
www.streetinsider.com - December 19 at 3:36 PM
4-traders.com logoAkers Biosciences : Signs Rapid Test Deal With US Hospital Association (NASDAQ:AKER)
www.4-traders.com - December 19 at 3:36 PM
proactiveinvestors.co.uk logoAkers Bio in landmark US agreement for heparin allergy test (NASDAQ:AKER)
www.proactiveinvestors.co.uk - December 19 at 3:36 PM
newsmaker.com.au logoGlobal Breath Analyzers Market – Drägerwerk AG & Co. KGaA , Alcohol Countermeasure Systems Corporation, Akers Biosciences (NASDAQ:AKER)
www.newsmaker.com.au - December 13 at 3:30 PM
News IconAkers Biosciences, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 (NASDAQ:AKER)
www.bioportfolio.com - December 2 at 8:35 PM
proactiveinvestors.co.uk logoDistribution deal a 'major, major win' for Akers Bio, says co-founder Ray Akers (NASDAQ:AKER)
www.proactiveinvestors.co.uk - December 2 at 10:43 AM
sbwire.com logoBreath Analyzer Market Will Hit USD 1,600.0 Million in 2021 (NASDAQ:AKER)
www.sbwire.com - December 1 at 8:30 PM
morningstar.co.uk logoAkers Agrees Deal For First Check To Sell Cholesterol Test In US (NASDAQ:AKER)
www.morningstar.co.uk - December 1 at 8:30 PM
us.rd.yahoo.com logo5:00 am Akers Biosciences completes the clinical trial for Diabetic Ketoacidosis Breath Test (NASDAQ:AKER)
us.rd.yahoo.com - November 30 at 8:27 PM
morningstar.co.uk logoAkers Biosciences: Clinical Trial For BreathScan "Highly Successful" (NASDAQ:AKER)
www.morningstar.co.uk - November 29 at 1:02 PM
streetinsider.com logoAkers Biosciences (AKER) Announces Completion of BreathScan DKA Trial; Results Seen as 'Highly Successful' (NASDAQ:AKER)
www.streetinsider.com - November 29 at 1:02 PM
proactiveinvestors.co.uk logoAkers Biosciences hails “highly successful” diabetes trial (NASDAQ:AKER)
www.proactiveinvestors.co.uk - November 29 at 1:02 PM
finance.yahoo.com logoAkers Biosciences Completes Clinical Trial for Rapid Diabetic Ketoacidosis Breath Test (NASDAQ:AKER)
finance.yahoo.com - November 29 at 1:02 PM
4-traders.com logoAkers Biosciences : Proposes Equity Raising For Growth, Working Capital (ALLISS) (NASDAQ:AKER)
www.4-traders.com - November 18 at 3:25 PM
capitalcube.com logoAkers Biosciences, Inc. :AKER-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 (NASDAQ:AKER)
www.capitalcube.com - November 18 at 12:43 PM
finance.yahoo.com logoAKERS BIOSCIENCES INC Financials (NASDAQ:AKER)
finance.yahoo.com - November 17 at 1:44 PM
reuters.com logoBRIEF-Akers Biosciences files for potential stock shelf, size not disclosed (NASDAQ:AKER)
www.reuters.com - November 16 at 3:28 PM
proactiveinvestors.co.uk logoAkers to launch “products of the future” in 2017 (NASDAQ:AKER)
www.proactiveinvestors.co.uk - November 15 at 12:28 PM

Social

What is Akers Biosciences' stock symbol?

Akers Biosciences trades on the NASDAQ under the ticker symbol "AKER."

When will Akers Biosciences announce their earnings?

Akers Biosciences is scheduled to release their next quarterly earnings announcement on Tuesday, March, 28th 2017.

How do I buy Akers Biosciences stock?

Shares of Akers Biosciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Akers Biosciences stock cost?

One share of Akers Biosciences stock can currently be purchased for approximately $1.30.

Akers Biosciences (NASDAQ:AKER) Chart for Tuesday, February, 28, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Akers Biosciences (NASDAQ:AKER)

Earnings History Chart

Earnings by Quarter for Akers Biosciences (NASDAQ:AKER)

Dividend History Chart

Dividend Payments by Quarter for Akers Biosciences (NASDAQ:AKER)

Last Updated on 2/28/2017 by MarketBeat.com Staff